what is really telling is what they do *show* on l2 ..
what is really telling is what they do *show* on l2 ..
that is why taking copies daily can *imo* prove revealing
when CANT isn't being *activated* for a reset .. CANT protects 30c
ETRF has shown 10000 @ .129c consistently ..
i asked a few of the longs i interact with regularly where they
expected NN to go when 5c was relo/d on the ask .. no one said 8c
(which is where NN went) .. all said 6c or 7c ..
reminder it was last September that the 52 week high went to 7c (on less
than 70000 in volume)
so i come back to what *volume* will be enough for CEs with the news of either
P2O's first sale and/or ancillary material events 8k'd
if VNDM has nothing behind their *visible* (previously elastic) ask @ 051
that leaves ECN for hire .. ARCA .. who does less than squat each month
and reports *every* trade re: ATS DARK POOL
and the *interchangeables* consistently utilized since 2010 and 2012
CSTI and CDEL (reminder CSTI imported to aid and abet NN in July 2010
and CDEL *shadowed* on PTOI for a year b4 *showing* volume in Sept 2012) are the ones left to *observe*
so .. with news .. watch to see what volume it takes to relo 5c/051 on ask
imo NN is already signaling the next level to protect is 10c
so the ? every has to ask themselves is how much *volume* picked off over
the last 3+ years (EO Dec 2013 .. PTOI compressed to 10c) mostly @ 10c
or below would be sold @ 10c?
most likely not much .. which is why tape of trades showing *resets* and
hidden mirrored trades .. proves so revealing .. yet again
which brings us to 20c .. which actually was mostly bypassed by the crooks
less than 1M in volume was done to break from low 30/s to upper teens
(again this is from memory .. but one reason why i remember this is because
i had a GTC that filled @ 19c)
so i have to ask yet again what gets sold @ 20c that was picked off from
Sept 30, 2013 .. when PTOI closed @ 35c and was taken on a trajectory
by NON RETAIL .. mostly straight down .. with one exception .. when CEs' almost
lost 20c (stopped out @ 19c) when P2O was issued multi year permits in
the summer of 2014 by NYSDEC
which of course our non promotional CEO shouted from the rafters .. NOT
the key PPS imo with 8ks' filed .. is 30c to 35c
but this is where *volume* becomes key .. will originals .. whose buy in price
isn't @ 35c .. sell out at 35c with a DA 8k'd or the implementation of an
internal sales/marketing team?
only they can answer that ? .. but i'm inclined to say no .. based on prior actions
i come back to the PPS range i do think sees *volume* and CEs' attentions
and that is 1.00 to 1.50 ..
with the caveat if they (CEs) can't source enough volume % wise b4 that 1.50 line in the sand
then it breaks
and it breaks in a manner that will be talked about for years
again PTOI has been illegally manipulated for almost 9 years and that piper
is coming due with P2O's first sale
4kids
1
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...
Continue Reading
When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....
Continue Reading
Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...
Continue Reading
Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...
Continue Reading
AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...
Continue Reading
Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...
Continue Reading
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...
Continue Reading
Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...
Continue Reading
The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...
Continue Reading
Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...
Continue Reading
Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...
Continue Reading